| Summary: | Background: RSUD dr. Soedarso is a hospital owned by Provincial
Government of West Borneo. The pharmacy installation of RSUD dr.
Soedarso is responsible in conducting pharmacy service comprising
planning, procurement, distribution and the usage. The drug planning is
conducted based on the average consumption per month and three
months. There are many prescription sheets that are not served since
there is no needed drug available. The drug expense should be suitable
with the drug necessity for the disease dealt with. In order to know the
preciseness, it is used two kinds of evaluation instrument, including ABC
analysis to view the drug that consumes large expense and VEN.
Purpose: Conducting analysis on the drug expense in 2010 is by ABC
analysis and VEN in order to assist RSUD dr. Soedarso to improve the
better planning of drug necessity.
Method: The research uses case study design with analytic descriptive
approach. The analysis is started by collecting the data of drug expense
and drug price list in each depot at IFRS dr. Soedarso starting from
January until December 2010. Thus, the data of drug expense in a year is
classified based on active substance, later on, the cumulative percentage
is counted and conducted ABC analysis. The result of ABC value, then, is
analyzed further by considering VEN criteria. Moreover, since the hospital
has not had medication standard yet, so the VEN criteria is based on
DOEN in 2008.
Result: 1) The drug expense process of RSUD dr. Soedarso uses
consumption method conducted by apothecary in every depot and
approved by Head of IFRS. Therefore, the team of drug special planning
has not been formed. Formularies have not been revised for ages. The
hospital has not had medication standard. 2) The result of ABC analysis
shows that the A category is 30 drug items, B category is 60 drug items
and C category is 257 drug items. The drug including V criteria is 9 drug
items, E criteria is 153 drug items and N criteria is 185 drug items.
Apparently, the A category is dominated by 13 drug items including in N
criteria, by absorbing the cost of drug expense is 1,86 billion IDR.
Conclusion: 1) The drug expense process of RSUD dr. Soedarso uses
consumption method done by apothecary in every depot and approved by
head of IFRS. RSUD dr. Soedarso has not formed team of integrated drug
special planning consisting of related parties as well as involving the
member of hospital KFT. 2) The 2010 drug expense has not effective and
efficient yet since it is more than half of non-essential drug item and
absorbs more than 39,6% of drug expense.
|
|---|